期刊文献+

结直肠癌原发灶与转移灶中EGFR表达的免疫组化研究 被引量:1

Study on epidermal growth factor receptor status in primary colorectal cancers and related metastatic sites
下载PDF
导出
摘要 目的观察表皮生长因子受体(EGFR)在结直肠癌原发灶及转移灶中的表达情况。方法采用免疫组织化学法检测37例(男25例,女12例)术后出现远处转移的结直肠癌患者原发灶及转移灶EGFR的表达情况,其中结肠癌16例(43.2%),直肠癌21例(56.8%),肝转移32例(86.5%),腹股沟淋巴结转移5例(13.5%)。EGFR阳性细胞≥5%即判定为阳性。结果37例中有25例(67.6%)原发灶EGFR阳性,其中7例(28.0%)对应的转移灶EGFR阴性。12例原发灶EGFR阴性者中,有3例(25.0%)对应的转移灶EGFR阳性。统计分析表明,原发灶与转移灶EGFR的表达无统计学差异(P=0.23)。结论转移性结直肠癌原发灶与转移灶的EGFR表达状态无显著性差异,其中大部分病例表达情况一致。 Objective Epidermal growth factor receptor (EGFR) plays an important role in the pathogenesis of colorectal cancer (CRC). There are several potential therapies to target EGFR The detection of EGFR expression is usually performed by immunohistochemistry (IHC) only in the primary tumor. There are a few data regarding the EGFR status in the corresponding distant metastases. The aim of the present study was to correlate EGFR expression in primary tumors and related metastases in order to find out whether EGFR status is different between primary tumors and related metastases. Methods 37 cases (25 male, 12 female) of metastatic colorectal cancer were collected. The site of primary tumor was on colon in 16 patients (43. 2%) and on rectum in 21 patients (56. 8%). Metastatic sites analyzed were liver in 32 patients (86. 5%), inguinal lymph nodes in 5 patients (13.5%). The EGFR status of prirrkary tumors and related metastatic sites were evaluated retrospectively. The expression of EGFR was analyzed by immunohistochemical staining (IHC), EGFR status was defined as positive if the percentage of stained malignant cells was ~5%, and the expression feature was analyzed. Results EGFR status was positive in 25 primary tumors (67. 6%), in which the corresponding metastatic site was negative in 7 eases (28. 0%), whereas it was posi tive in 3 metastases (25. 0%) from 12 cases of EGFR-negafive primary cancers. The difference between the priruary tumors and metastatic lesions had no statistic significance (P=0. 23). Conclusion When analyzed by IHC, The difference of EGFR status has no statistic significance between the paired primary tumors and distant metastatic lesions, and 73% of samples show concordant EGFR status
出处 《解放军医学杂志》 CAS CSCD 北大核心 2008年第1期80-81,共2页 Medical Journal of Chinese People's Liberation Army
关键词 结直肠肿瘤 受体 表皮生长因子 肿瘤转移 colorectal neoplasms receptor, epidermal growth factor neoplasm metastasis
  • 相关文献

参考文献9

  • 1姚根有,阮俊,赵仲生,胡云琴.细胞周期素E和表皮生长因子受体在乳腺癌中的表达及与预后的关系[J].中华普通外科杂志,2004,19(8):483-485. 被引量:4
  • 2Herbst RS, Shin DM. Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy. Cancer, 2002, 94(5): 1593
  • 3Petit AM, Rak J, Hung MC, et al. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduc tion therapy of solid tumors. Am J Pathol, 1997, 151(6) :1523
  • 4Aziz SA, Pervez S, Khan S, et al. Epidermal growth factor receptor (EGFR) as a prognostic marker: an study on 315 consecutive breast carcinoma patients J Pak Med Assoc, 2002, 52(3):104
  • 5Prewett M, Rockwell P, Rockwell RF, et al. The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma. J Immunother Emphasis Tumor Immunol, 1996, 19 (6) :419
  • 6Naramura M, Gillies SD, Mendelsohn J, et al. Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma. Cancer Immunol Immunother, 1993, 37(5):343
  • 7Scartozzi M, Bearzi I, Berardi R, et al. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoelonal antibodies. J Clin Oncol, 2005, 23(1): 248
  • 8Italiano A, Saint-Paul MC, Caroli-Bosc FX, et al. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors correlates with EGFR expression in related metastatic sites: biological and clinical implications Ann Oncol, 2005, 16(9):1503
  • 9Tos AP, Ellis I. Assessing epidermal growth factor receptor expres sion in tumours: what is the value of current test methods? Eur J Cancer, 2005, 41(10):1383

二级参考文献4

  • 1Keyoumarsi K,Oleary N,Molnar G,et al.Cyclin E,a potential prognostic marker for breast cancer.Cancer Res,1994,54:380-385.
  • 2Donnelan R,Kleinschmidt I,Chetty R.Cyclin E immuno-expression in breast ductal carcinoma:pathologic correlations and prognostic implications.Hum Pathol,2001,32:89-94.
  • 3Kim HK,Park IA,Heo DS,et al.Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer.Eur J Surg Oncol,2001,27:464-471.
  • 4Kopp R,Rothballer E,Ruge M,et al.Clinical implications of the EGF receptor/ligant system for tumor progression and survival in gastrointestinal carcinomas:evidence for new therapeutic options.Recent Result Cancer Res,2003,162:115-132.

共引文献3

同被引文献16

引证文献1

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部